Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

August 2016

Medicare Poised to Hit Pathologists’ Income, Again!

IN JANUARY, THE MEDICARE PROGRAM WILL INTRODUCE a new reimbursement scheme for physicians that will alter the income for every pathologist who treats Medicare patients. Just the fact that the federal Centers for Medicare & Medicaid Services wants to tinker in a substantial way with how it pays physicians should catch the full attention of …

Medicare Poised to Hit Pathologists’ Income, Again! Read More »

To access this post, you must purchase The Dark Report.

Elizabeth Holmes of Theranos Speaks at AACC To Skeptical PhDs, Pathologists, and Press

CEO SUMMARY: Elizabeth Holmes, Founder and CEO of Theranos, Inc., was given the ideal platform by AACC to show the science behind her lab company’s much-touted diagnostic technologies. But in a surprise to the assembled audience, Holmes, accompanied by three PhDs on her team, chose to discuss: a) her company’s new business strategy; b) an …

Elizabeth Holmes of Theranos Speaks at AACC To Skeptical PhDs, Pathologists, and Press Read More »

To access this post, you must purchase The Dark Report.

Ohio State University Medical Center Inks Pact To Adopt Digital Pathology

CEO SUMMARY: For years, the adoption of digital pathology has lagged behind the predictions of its advocates. That has encouraged one digital pathology company—Inspirata, Inc., of Tampa—to come up with a different business strategy designed to help anatomic pathology labs address the barriers and capital costs involved with establishing a digital pathology system. The Ohio …

Ohio State University Medical Center Inks Pact To Adopt Digital Pathology Read More »

To access this post, you must purchase The Dark Report.

GE, UPMC Ending Omnyx, Their Digital Pathology Joint Venture

IN RECENT WEEKS, pathology laboratory clients of the Omnyx digital pathology system learned that the joint venture is ending. Company officials tell these customers that their digital pathology systems will continue to receive service. Omnyx was formed in 2008 as a joint venture between GE Healthcare and the University of Pittsburgh Medical Center (UPMC). Its …

GE, UPMC Ending Omnyx, Their Digital Pathology Joint Venture Read More »

To access this post, you must purchase The Dark Report.

Cigna Expands Program For Genetic Counseling When Genetic Tests Are Needed

CEO SUMMARY: For three years, Cigna has required genetic counseling for members seeking genetic testing for hereditary breast, ovarian, and colorectal cancer, and for a particular heart condition. Such counseling increased member satisfaction, causing Cigna to expand the program. It now requires genetic counseling with an independent board-certified genetics specialist for members considering whole exome …

Cigna Expands Program For Genetic Counseling When Genetic Tests Are Needed Read More »

To access this post, you must purchase The Dark Report.

August 15, 2016 Intelligence: Late Breaking Lab News

One of the nation’s largest private pathology group practices completed a successful recapitalization, thus ensuring its independence for another five to seven years. On August 1, PathGroup, Inc., of Nashville, Tenn., announced an investment by Pritzker Group Private Capital and Vesey Street Capital Partners. It was in January 2010, that PathGroup had completed a $100 million …

August 15, 2016 Intelligence: Late Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

Anatomic Pathology Profession Faces Challenges, Opportunities

CEO SUMMARY: For 10 years, three primary trends have reshaped the anatomic pathology profession. They are declining reimbursement, competition from physicians establishing in-office pathology labs, and a host of new government laws and regulations. More changes are coming, predicts one business expert in pathology. Those changes involve new Medicare payment models, along with opportunities for …

Anatomic Pathology Profession Faces Challenges, Opportunities Read More »

To access this post, you must purchase The Dark Report.

Score for Theranos after AACC: Fail.

This is an excerpt from a 1,600-word article in the August 15 issue of THE DARK REPORT. The complete article is available to paid members of the Dark Intelligence Group. SKEPTICS WHO WEREN’T EXPECTING MUCH from Theranos CEO Elizabeth Holmes at the recent American Association of Clinical Chemistry’s annual meeting were proved right: Instead of delivering …

Score for Theranos after AACC: Fail. Read More »

To access this post, you must purchase The Dark Report.

;